← All diseases Cancer

Multiple myeloma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (64)Meta-analysis (11)Treatment guideline (2)Systematic review (24)Randomized trial (16)Phase 3 study (11)Clinical trial (628)Review Article (260)Early study (phase 1 or 2) (44)Case Reports (256)Laboratory or animal study (23)Commentary or editorial (45)Retracted Publication (4)Concerns have been raised (1) Studies currently recruiting participants only (46)

Filter

Publications and studies (2183)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Tissue factor-bearing extracellular vesicles, procoagulant phospholipids and D-dimer as potential biomarkers for venous thromboembolism in patients with newly diagnosed multiple myeloma: A comprehensive analysis. (2025/03/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study. (2025/03/01) ♡
• Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption. (2025/02/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. CART-induced eosinophilic colitis with good response to corticosteroids and infliximab: a case report. (2025/02/26) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multimodality Imaging Findings in Cardiac Plasmacytoma. (2025/02/19) ♡
• Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Significance of Pre-Transplant Controlling Nutritional Status Score. (2025/02/12) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. 18F-FDG PET/CT Imaging of Cutaneous and Intramuscular Multiple Myeloma. (2025/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advancements in bispecific antibodies for multiple myeloma: What's new and what lies ahead. (2025/02/01) ♡
• Allogeneic Stem Cell Transplantation for High/Ultra High-Risk Multiple Myeloma. (2025/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients. (2025/02/01) ♡
• Exploring the role of circulating proteins in multiple myeloma risk: a Mendelian randomization study. (2025/01/30) ♡
• PCMMD: A Novel Dataset of Plasma Cells to Support the Diagnosis of Multiple Myeloma. (2025/01/27) ♡
• The association between the dietary inflammatory index and multiple myeloma: a case-control study. (2025/01/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies. (2025/01/21) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia. (2025/01/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma. (2025/01/16) ♡
• Documentation of International Staging System (ISS) and Revised International Staging System (R-ISS) for Multiple Myeloma at a Tertiary Care Center: A Clinical Audit. (2025/01/01) ♡
• Assessing chromosomal abnormalities in leukemias by imaging flow cytometry. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent Updates in the Diagnosis and Management of Kidney Diseases in Multiple Myeloma. (2025/01/01) ♡
• Occurrence of Monoclonal Band in Alpha Region on Serum Electrophoresis in Multiple Myeloma: A Diagnostic Conundrum. (2025/01/01) ♡
• Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients. (2025/01/01) ♡
• Correlation of Flame Cells and Two Monoclonal Bands in Beta and Gamma Region in IgA Multiple Myeloma. (2025/01/01) ♡
• Assessment of the Prognostic Importance of The Revised International Staging System Based on Plasmacytoma Presentation in Recently Diagnosed Patients with Multiple Myeloma. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma. (2025/01/01) ♡
• Respiratory syncytial virus and other vaccine-preventable infections in multiple myeloma. A population-based study on 8,672 myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. piR-823 tale as emerging cancer-hallmark molecular marker in different cancer types: a step-toward ncRNA-precision. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Refining High-Risk Multiple Myeloma: Advancements in Genomic, Clinical, and Prognostic Criteria. (2025/01/01) ♡
• Income and education affect prognosis and treatment in symptomatic myeloma : A population-based study on 8672 multiple myeloma patients diagnosed 2008-2021 from the Swedish myeloma registry. (2025/01/01) ♡
• Tumor Suppressor and Oncogenic miRNA Expressions in Patients with Type I Gaucher Disease and Carriers. (2025/01/01) ♡
• Exercise and Diet Studies Among Patients Living with Multiple Myeloma: Current Evidence and Considerations of Patient Preferences. (2025/01/01) ♡
• Aberrant expression of CD markers in patients with acute leukemia. (2025/01/01) ♡
• CSF3R Gln776X and ASXL1 mutations in multiple myeloma associated with chronic neutrophilic leukemia: case report and literature review. (2024/12/31) ♡
• Impact of neurotoxicity and steroid therapy on cancer progression-free survival in lymphoma patients treated with anti-CD19 CAR T cells. (2024/12/31) ♡
• A Retrospective Analysis of Morbidity and Risk Factors of Multiple Myeloma with Peripheral Neuropathy. (2024/12/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [BCMA/CS1 bispecific CAR-T cell therapy for multiple myeloma complicated with thrombocytopenia: a case report and literature review]. (2024/12/30) ♡
• The Positive Effects of Training and Time-Restricted Eating in Gut Microbiota Biodiversity in Patients with Multiple Myeloma. (2024/12/27) ♡
• Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience. (2024/12/27) ♡
• Population differences in the associations between chromosomal abnormalities and overall survival of multiple myeloma. (2024/12/26) ♡
• Optimized BCMA/CS1 bispecific TRuC-T cells secreting IL-7 and CCL21 robustly control multiple myeloma. (2024/12/24) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Markedly T2-Hypointense Clival Plasmacytoma With Light Chain Deposition Disease: A Case Report. (2024/12/23) ♡
• Romiplostim Reduces Platelet Transfusion Needs in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation. (2024/12/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review. (2024/12/20) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Plasmablastic myeloma with a history of diffuse large B-cell lymphoma. (2024/12/20) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapy. (2024/12/20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prehabilitation Exercise Training to Target Improved Muscle Strength in Pretransplant Patients Diagnosed With Multiple Myeloma: Protocol for a Pilot Randomized Controlled Trial. (2024/12/19) ♡
• The Prevalence and Diagnostic Patterns of Oral and Maxillofacial Lesions: A Seven-Year, Retrospective, Single-Center Cone Beam Computed Tomography and Histopathology Study in Saudi Arabia. (2024/12/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Periorbital necrobiotic xanthogranuloma resolved with three years of systemic lenalidomide treatment. (2024/12/19) ♡
• Retrospective claims data analysis of ASCT characteristics and costs for working-age, multiple myeloma patients in the US, 2017-2019. (2024/12/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Lambda Light Chain Cast Nephropathy Caused by Splenic Marginal Zone Lymphoma. (2024/12/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cutaneous Plasmacytosis: A Rare Dermatological Condition Mimicking Systemic Plasma Cell Disorders. (2024/12/18) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.